Delivery Order SPE2DB20D3103-SPE2DB25FN9V9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,702.70 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,051.05 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,683.10 to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with a June 10, 2025 completion date. This firm fixed-price, competitively awarded contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,205.56 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens on May 21, 2025, with completion scheduled for May 22, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product, Trulicity (dulaglutide), is a diabetes...
- The Defense Logistics Agency awarded a $4,416.87 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on July 18, 2025, with a completion date of July 21, 2025. This competitively awarded, non-set-aside contract represents a routine pharmaceutical delivery under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion master contract valued through December 2026. The place of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $7,167.48 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on August 13, 2025. This competitively awarded, firm fixed-price contract represents a single delivery transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's location in Conshohocken, Pennsylvania, with an ultimate completion date of August...
- The Defense Logistics Agency awarded a $4,881.77 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens with an ultimate completion date of July 30, 2025. This is a firm fixed price, non-set-aside delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. Trulicity, a diabetes medication, represents one of the broad range of pharmaceutical products the company supplies through...
- The Defense Logistics Agency awarded a $8,513.14 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pens with an ultimate completion date of June 18, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The product will be delivered to AmerisourceBergen's...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FN9V9Delivery Order
The Defense Logistics Agency awarded a $12,966.78 delivery order to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on May 29, 2025, with completion required by May 30, 2025. This is a firm fixed-price, non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly supplied through the company's comprehensive pharmaceutical distribution network supporting military healthcare systems. This delivery order represents a routine transaction within AmerisourceBergen's extensive federal contract portfolio with the Defense Logistics Agency, which includes a wide spectrum of pharmaceutical products and medical supplies across multiple therapeutic domains. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply critical medical commodities including specialty medications, vaccines, and medical devices to support Department of Defense health systems worldwide. As a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare procurement, AmerisourceBergen regularly fulfills competitively awarded delivery orders of varying values, demonstrating its capacity to meet diverse federal medical supply requirements through established contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 5/29/25 |